Columbia University

Technology Ventures

Venture Capital Investing in the Biotech Startup Space

May 02, 2017
Charlotte Hubbert
Faculty Club
Columbia University Medical Center
630 West 168th Street, Fourth Floor
New York, NY 10032

Join Columbia WIN for a discussion exploring venture capital investing in biotech companies with Charlotte Hubbert of The Bill & Melinda Gates Foundation. Charlotte brings a wealth of experience in venture capital investing, startups, and emerging biotechnology, having previously served as Vice President with H.I.G. BioVentures and an associate at Accelerator Corporation, where she was involved in the strategic development and management of many companies including Oncofactor, Groove Bipharma, and Acylin Therapeutics.

Following the presentation, there will be a networking reception with drinks and appetizers in the same location from 6 to 7 pm.

This event is open only to guests with valid Columbia University IDs. We regret that we are unable to accommodate guests from outside Columbia for this event.

Dr. Charlotte Hubbert is a Program Investment Officer focusing on Venture Capital investments at The Bill & Melinda Gates Foundation. She serves on the BOD of Synlogic Therapeutics and Sera Prognostics.

Prior to joining The Bill & Melinda Gates Foundation, Charlotte was a Vice-President with H.I.G.BioVentures focusing on investment opportunities in the life sciences, including therapeutics, diagnostics and medical devices. Previously, she was an Associate at Accelerator Corporation, an investment vehicle focused on identifying, evaluating, financing and managing emerging therapeutic technologies. During her tenure, Charlotte was involved in the strategic development and management of five companies, including Oncofactor, Groove Biopharma, Acylin Therapeutics, Xori and Pharmselex. Charlotte also currently serves as a member of the Scientific Advisory Board for Oncofactor Corporation.

Charlotte earned a B.S. in Microbiology from the University of Washington and a Ph.D. in Pharmacology and Cancer Biology from Duke University. She did her post-doctoral work in stem cells and regenerative medicine at the Institute for Stem Cells and Regenerative Medicine at the University of Washington. Charlotte is a member of the Kauffman Society of Fellows (Class 14). The Kauffman Society is a network of venture capitalists operating at 160 venture organizations in 26 countries on 6 continents, collectively deploying $50B in capital.